Cronos Group Ups Investment in Whistler Medical Marijuana

TORONTO, March 9, 2017 /CNW/ – Cronos Group Inc. (TSXV: MJN) (OTC: PRMCF) (“Cronos Group” or the “Company”) owns a 21.5% stake in Whistler Medical Marijuana Corp. (“WMMC” or “Whistler”) and is pleased to announce that WMMC has been granted an affirmation letter from Health Canada regarding the company’s announced 65,000 square foot expansion in Pemberton, British Columbia.  Cronos continues to be impressed with the capital efficiencies, brand equity, premium organic product and the unique culture, vision and leadership at Whistler.  Accordingly, the Company has decided to maintain its 21.5% equity position through an additional $1,085,000 investment (at a $75MM pre-money valuation) to help support WMMC’s next phase of growth.

Whistler was among the very first licensed producers in Canada and is the only actively selling LP whose entire product line is 100% certified organic. In response to significant growth in sales

... read more at: